Factors of osteogenesis influencing various human stem cells on third-generation gelatin/β-tricalcium phosphate scaffold material

Rejuvenation Research

Volumn 14, Issue 2, 2011, Pages 185-194

  Weinand, Christian ^a   Nabili, Afshin ^b   Khumar, Mohammed ^c   Dunn, Joey R ^a   Ramella Roman, Jessica ^b   Jeng, James C ^a   Jordan, Marion H ^a   Tabata, Yasuhiko ^d  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b CATHOLIC UNIVERSITY OF AMERICA   (United States)

^c Department of Histopathology ^*  (United States)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATE; GELATIN; TOLUIDINE DERIVATIVE;

ADIPOSE DERIVED STEM CELL; ADULT; ARTICLE; BIOMECHANICS; BONE DENSITY; BONE DEVELOPMENT; BONE REGENERATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CULTURE MEDIUM; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; STAINING;

ADULT; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; CALCIUM PHOSPHATES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; GELATIN; HUMANS; MIDDLE AGED; OSTEOGENESIS; STEM CELLS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 79957445346     PISSN: 15491684     EISSN: 15578577     Source Type: Journal    
DOI: 10.1089/rej.2010.1105     Document Type: Article

References (36)

1. Stevens MM. Biomaterials for bone tissue engineering. Materials Today 2008;11:18-25. (Pubitemid 351539115)
2. Bauer TW, Muschler GF. Bone graft materials. An overview of the basic science. Clin Orthop Relat Res 2000;371: 10-27. (Pubitemid 30090817)
3. Silber JS, Anderson DG, Daffner SD, Brislin BT, Leland JM, Hilibrand AS, Vaccaro AR, Albert TJ. Donor site morbidity after anterior iliac crest bone harvest for single-level anterior cervical discectomy and fusion. Spine 2003;28:134-139. (Pubitemid 36110079)
4. Lord CF, Gebhardt MC, Tomford WW, Mankin HJ. Infection in bone allografts. Incidence, nature, and treatment. J Bone Joint Surg Am 1988;70:369-376.
5. Langer R, Vacanti JP. Tissue Engineering. Science 1993;260: 920-926. (Pubitemid 23209960)
6. Hench LL, Polak JM. Third-generation biomedical materials. Science 2002;295:1014-1017.
7. Zijderveld SA, Zerbo IR, van den Bergh JP, Schulten EA, ten Bruggenkate CM. Maxillary sinus floor augmentation using a beta-tricalcium phosphate (Cerasorb) alone compared to autogenous bone grafts. Int J Oral Maxillofac Implants 2005;20:432-440. (Pubitemid 40905499)
8. MA PX, Choi JW. Biodegradable polymer scaffolds with well-defined interconnected spherical pore network. Tissue Eng 2001;7:23-33. (Pubitemid 32175959)
9. Zhao F, Yin Y, Lu WW, Leong JC, Zhang W, Zhang J, Zhang M, Yao K. Preparation and histological evaluation of biomimetic three-dimensional hydroxyapatite/chitosan-gelatin network composite scaffolds. Biomaterials 2002;23:3227-3234. (Pubitemid 34522135)
10. Weinand C, Pomerantseva I, Neville CM, Gupta R, Weinberg E, Madisch I, Abukawa H, Troulis MJ, Vacanti JP. Hydrogel-b-TCP scaffolds and stem cells for tissue engineering bone. Bone 2006;38:555-563.
11. Takahashi Y, Yamamoto M, Tabata Y. Osteogenic differentiation of mesenchymal stem cells in biodegradable sponges composed of gelatin and b-tricalcium phosphate. Biomaterials 2005;26:3587-3596. (Pubitemid 40038153)
12. Zekorn D. Intravascular retention, dispersal, excretion and breakdown of gelatin plasma substitutes. Bibl Haematol 1969;33:131-140.
13. Bordenave L, Caix J, Basse-Cathalinat B, Baquey C, Midy D, Baste JC, Constans H. Experimental evaluation of a gelatincoated polyester graft used as an arterial substitute. Biomaterials 1989;10:235-242. (Pubitemid 19142722)
14. Warocquier-Clerout R, Lee YS, Penhoat J, Sigot-Luizard MF. Comparative behaviour of L-929 fibroblastic and human endothelial cells onto crosslinked protein substrates. Cytotechnology 1990;3:259-269.
15. Ma Z, Gao C, Gong Y, Ji J, Shen J. Immobilization of natural macromolecules on poly-L-lactic acid membrane surface in order to improve its cytocompatibility. J Biomed Mater Res 2002;63:838-847. (Pubitemid 35375433)
16. Patel ZS, Yamamoto M, Ueda H, Tabata Y, Mikos AG. Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2. Acta Biomater 2008;4:1126-1138.
17. Pei M, Solchaga LA, Seidel J, Zeng L, Vunjak-Novakovic G, Caplan AI, Freed LE. Bioreactors mediate the effectiveness of tissue engineering scaffolds. FASEB 2002;16:1691-1694.
18. Greenwood FC, Hunter WM, Glover TC. The preparation of I-131 labeled growth hormone of high specific radiosensitivity. Biochem J 1963;89:114-123.
19. Kern S, Eichler H, Stoeve J, Klüter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006;24:1294-1301. (Pubitemid 44464698)
20. Liu TM, Martina M, Hutmacher DW, Hui JH, Lee EH, Lim B. Identification of common pathways mediating differentiation of bone marrow- and adipose tissue derived human mesenchymal stem cells into three mesenchymal lineages. Stem Cells 2007;25:750-760. (Pubitemid 46354235)
21. Hayashi O, Katsube Y, Hirose M, Ohgushi H, Ito H. Comparison of osteogenic ability of rat mesenchymal stem cells from bone marrow, periosteum, and adipose tissue. Calcif Tissue Int 2008;82:238-247.
22. Mauney JR, Volloch V, Kaplan DL. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion. Biomaterials 2005;26:6167-6175. (Pubitemid 40826985)
23. Takahshi Y, Yamamoto M, Tabata Y. Osteogenic differentiation of mesenchymal stem cells in biodegradable sponges composed of gelatin and beta-tricalcium phosphate. Biomaterials 2005;26:3587-3596. (Pubitemid 40038153)
24. Guilak F, Estes BT, Diekman BO, Moutos FT, Gimble JM. 2010 Nicolas Andry Award: Multipotent adult stem cells from adipose tissue for musculoskeletal tissue engineering. Clin Orthop Relat Res 2010;468:2530-2534.
25. Mosna F, Sensebé L, Krampera M. Human bone marrow and adipose tissue mesenchymal stem cells: A user's guide. Stem Cells Dev 2010;19:1449-1470.
26. Rider DA, Dombrowski C, Sawyer AA, Ng GH, Leong D, Hutmacher DW, Nurcombe V, Cool SM. Autocrine fibroblast growth factor 2 increases the multipotentiality of human adipose-derived mesenchymal stem cells. Stem Cells 2008;26:1598-1608.
27. Zannettino AC, Paton S, Arthur A, Khor F, Itescu S, Gimble JM, Gronthos S. Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J Cell Physiol 2008;214:413-421. (Pubitemid 350308998)
28. Niemeyer P, Fechner K, Milz S, Richter W, Suedkamp NP, Mehlhorn AT, Pearce S, Kasten P. Comparison of mesenchymal stem cells from bone marrow and adipose tissue for bone regeneration in a critical size defect of the sheep tibia and the influence of platelet-rich plasma. Biomaterials 2010;31:3572-2579.
29. Gupta A, Leong DT, Bai HF, Singh SB, Lim TC, Hutmacher DW. Osteomaturation of adipose-derived stem cells required the combined action of vitamin D3, betaglycerophosphate, and ascorbic acid. Biochem Biophys Res Commun 2007;362:17-24. (Pubitemid 47296287)
30. Yamamoto M, Tabata Y. Tissue engineering by modulated gene delivery. Adv Drug Deliv Rev 2006;58:535-554. (Pubitemid 43928171)
31. Fukunaka Y, Iwanaga K, Morimoto K, Kakemi M, Tabata Y. Controlled release of plasmid DNA from cationized gelatin hydrogels based on hydrogeldegradation. J Contr Release 2002;80:333-343. (Pubitemid 34273770)
32. Kushibiki T, Tomoshige R, Fukunaka Y, Kakemi M, Tabata Y. In vivo release and gene expression of plasmid DNA by hydrogels of gelatin with different cationization extents. J Contr Release 2003;90:207-216. (Pubitemid 36694964)
33. Yamamoto M, Tabata Y. Tissue engineering bymodulated gene delivery. Advanced Drug Delivery Review 2006;58:535-554. (Pubitemid 43928171)
34. Tabata Y. Significance of release technology in tissue engineering. Drug Discovery Today 2005;10:1639-1646. (Pubitemid 41817612)
35. Bruder SP, Horowitz MC, Mosca JD, Haynesworth SE. Monoclonal antibodies reactive with human osteogenic cell surface antigens. Bone 1997;21:225-235. (Pubitemid 27404080)
36. Rebelatto CK, Aguiar AM, Moretao MP, Senegaglia AC, Hansen P, Barchiki F, Oliveria J, Martins J, Kuligovski C, Mansur F, Christofis A, Amarel VF, Brofman PS, Goldenberg S, Nakao LS, Correa A. Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Exp Biol Med (Marywood) 2008;233:901-913.